The ordinary miracle begins after the appointment. A veterinarian decides what a pet needs. A prescription is written. Then medicine must leave a shelf, survive a thicket of rules, land at the correct address, and be given on the correct Tuesday by a person who may also be answering email, cooking dinner, and wondering why the dog has learned to detect a pill inside peanut butter. Andy Bane has spent nearly two decades attending to this unphotogenic middle.
It is a career built less around revelation than follow-through. Bane is chief executive of Vetsource, the Portland company that began with prescription management and home delivery and grew into a wider collection of pharmacy, data, and client-engagement services for veterinary practices. He joined the founding team in 2006, became its operating constant, and stepped into the top job in 2025. If the title sounds like a new chapter, the subject has barely changed: how to make a recommendation in a clinic become care at home.
First, study the behavior
Bane did not take the familiar route into pet care. He was not trained as a veterinarian, pharmacist, or software engineer. At Colorado State University, he earned a master's degree and a doctorate in physiological psychology, also described as behavioral neuroscience. His postdoctoral work at Bowman-Gray School of Medicine involved directing behavioral tests of experimental compounds. The measures included movement, anxiety, learning, memory, hyperactivity, and temperature. The work required chemists, pharmacologists, toxicologists, and behavioral researchers to agree on what they were observing and why it mattered.
That education turns out to be an excellent preface to logistics. A pharmacy operation is full of behavior disguised as process. Someone authorizes. Someone checks. Someone packs. Someone remembers. The system is only as sound as the sequence, and the sequence is only real when people can repeat it. The laboratory and the loading dock are not neighbors, but they share a stern opinion about missed steps.
After academia, Bane moved quickly across different working worlds. He co-founded Premier Veterinary Hospitals, started a computer consulting business, and served as chief operating officer at the apparel company Scott Barber. Human pharmaceuticals followed, with roles at Bristol-Myers Squibb and Teva. By the time he arrived at the early Vetsource, he had accumulated an eccentric but useful kit: experimental discipline, software exposure, startup experience, drug-industry knowledge, and a COO's appetite for the details everyone else prefers to discover only when they fail.
A business hidden inside a handoff
Vetsource's early proposition was plain enough to fit on a label: help veterinary practices offer prescribed products online and send them to pet owners at home. The simplicity was the sales pitch. The complexity was the business. Animal prescriptions sit in a peculiar channel among doctors, manufacturers, distributors, regulated pharmacies, clinics, and consumers. Each participant has duties, incentives, and computer systems of its own. The pet, reasonably, has no interest in the org chart.
The prescription, after the exam room
In 2012, Bane carried those details into a public workshop held by the Federal Trade Commission. He was Vetsource's chief operating officer, appearing in a discussion about the distribution and portability of pet medications. His contribution was characteristically concrete. Access mattered, but so did trained pharmacists, authentic supply, appropriate counseling, and the veterinarian's place in the process. A contemporaneous account reduced one of his points to a brisk sentence: pharmacists filling animal prescriptions need training in veterinary medicine to protect pets.
This was not a founder performing futurism. It was an operator describing the bolts. Veterinary prescriptions can involve dosages, species, flavors, formulations, and uses that do not map neatly onto human pharmacy. The convenience of a parcel means little if the expertise behind it is generic. Bane's version of innovation has always carried a clipboard.
The aisle becomes a platform
The 2015 photograph of Bane and then-CEO Kurt Green catches the company at its most literal. They stand between tall rows of medication bins. Green holds an open laptop displaying the online storefront. There, in one frame, is the entire argument: software in front, pharmacy behind, two operators in the narrow space between them.
Vetsource later widened that aisle. It acquired VetSuccess, a veterinary data and analytics business, in 2018 and Vet2Pet, a client-engagement platform, in 2019. In 2022, the three identities were brought under a unified Vetsource brand. Home delivery remained, but it gained company: practice dashboards, performance information, automated communication, loyalty tools, and mobile engagement. The work moved upstream from filling an order to helping a clinic understand and sustain the relationship that produces it.
The expansion makes sense through the lens of Bane's original field. Compliance is partly a supply problem and partly a behavior problem. A medication that never arrives cannot help. Neither can one that arrives and sits unopened. Data can show a practice where care is slipping. Communication can prompt the next action. Pharmacy can complete it. The pieces are commercially distinct and behaviorally inseparable.
The operator's long view
Longevity in a startup is often presented as romance. In operations, it is mostly memory. Bane was around for the cramped version of the company, the warehouse version, the acquisition version, and the regulated national-platform version. He could remember which workaround had become infrastructure and which principle had survived merely because nobody had time to challenge it. That kind of institutional memory can be ballast or baggage. His promotion suggests Vetsource saw ballast.
Graduate and postdoctoral work in behavioral science.
Roles in human pharmaceuticals at Bristol-Myers Squibb and Teva.
Joins the founding team that develops Vetsource.
Represents Vetsource at the FTC's pet-medications workshop.
Vetsource expands into data and client engagement, then unifies the brands.
Succeeds Kurt Green as chief executive.
The succession itself was personal. Green announced his move toward retirement by calling Bane his longtime friend and partner. It was a revealing phrase for a pair whose jobs had divided vision from execution without pretending the two were strangers. When Bane took the CEO position, he inherited a company already larger and more complicated than the service he had helped begin. He also inherited the need to keep its complexity from reaching the customer.
Even his public regulatory work kept the same tone. In 2024, commenting during a Kentucky Board of Pharmacy rulemaking process, Bane argued that a proposed requirement could add administrative weight without a corresponding improvement in patient care. He asked for room to account for veterinary pharmacy operations and the centralized systems used to manage state-by-state compliance. One may agree or disagree with the policy position. What is unmistakable is the operating mind at work: trace the rule to the workflow, then ask where safety improves.
National pharmacy work makes that question unavoidable. A package may travel in a straight line while the permission to send it crosses a patchwork. Licenses, dispensing rules, pharmacist responsibilities, recordkeeping, and practice procedures can vary by jurisdiction. Scale does not erase those differences; it gives them a shared loading dock. The operator's challenge is to centralize enough knowledge to be consistent without sanding away the reason a rule exists. Bane's public comments reveal someone less interested in regulation as theater than in its final destination. Does the policy change the check a pharmacist performs? Does it prevent an error? Does it improve access? Or does it simply add another handoff to a chain already rich in them? These are modest questions, which is another way of saying they are difficult to dodge.
The box is the proof
Executives in technology are rewarded for speaking about the future. Bane tends to speak about the network. Manufacturers, veterinarians, pharmacists, practice teams, pet owners, and other participants all appear in his description of Vetsource. His company sits among them, less a dazzling object than a useful verb: coordinate.
That restraint suits veterinary pharmacy. The best fulfillment experience is almost comically uneventful. The prescription is correct. The pharmacist is equipped to answer the question. The package arrives. The reminder arrives before the memory fails. The practice stays connected to the client. The animal receives the care. There is no ribbon-cutting for Tuesday going according to plan.
Bane's career has crossed science, clothing, consulting, human drugs, veterinary hospitals, ecommerce, data, and software. Yet the apparent zigzag resolves into a single preoccupation: systems that guide people from intention to action. Behavioral science gave him the question. Operations gave him the tools. Vetsource gave him a long enough runway to make the answer tangible.
Somewhere tonight, a pet owner will open a small cardboard box, glance at the label, and place the next dose beside tomorrow's coffee cup. It will not feel like infrastructure. If Bane and his colleagues have done their work, it will hardly feel like anything at all.